Results 71 to 80 of about 240,995 (321)

Pressure-Volume Loop Analysis in Percutaneous Coronary Intervention-Induced Shock

JACC: Case Reports, 2020
High-risk percutaneous coronary intervention may lead to undesirable clinical scenarios such as cardiogenic shock. We describe the hemodynamic changes using pressure-volume loop analyses in percutaneous coronary intervention-induced shock.
Admir Dedic, MD, PhD, Marcelo B. Bastos, MD, Nicolas M. Van Mieghem, MD, PhD   +2 more
doaj   +1 more source

Mechanical chest-compression devices: current and future roles [PDF]

, 2010
Purpose of review: It is recognised that the quality of CPR is an important predictor of outcome from cardiac arrest yet studies consistently demonstrate that the quality of CPR performed in real life is frequently sub-optimal.
Brace, Samantha J., Gates, Simon, Perkins, Gavin D.   +2 more
core   +1 more source

Design, Control, and Clinical Applications of Magnetic Actuation Systems: Challenges and Opportunities

Advanced Intelligent Systems, Volume 7, Issue 3, March 2025.
This review aims to provide a broad understanding for interdisciplinary researchers in engineering and clinical applications. It addresses the development and control of magnetic actuation systems (MASs) in clinical surgeries and their revolutionary effects in multiple clinical applications.
Yingxin Huo, Lidong Yang, Tiantian Xu, Dong Sun   +3 more
wiley   +1 more source

Vascular Access in Percutaneous Coronary Intervention of Chronic Total Occlusions: A State-of-the-Art Review [PDF]

, 2023
T Meijers, Adel Aminian, Marco Valgimigli, Joseph Dens, Pierfrancesco Agostoni, Juan F. Iglesias, Gabriele Gasparini, Arnold H. Seto, Shigeru Saito, Sunil V. Rao, Niels van Royen, Emmanouil S. Brilakis, Maarten A.H. van Leeuwen   +12 more
openalex   +1 more source

Implantable Drug Delivery Systems for Skeletal Muscles and Eyes

Advanced NanoBiomed Research, EarlyView.
This review highlights the different types of recent implantable drug delivery systems (IDDS) fabricated for a use with skeletal muscles, and with eyes. It presents the developments already made and the current research directions, showing the evolution of IDDS and their great diversity.
Serge Ostrovidov, Murugan Ramalingam, Hongkai Wu, Toshinori Fujie, Yukinari Nakamura, Takeshi Hori, Yuji Nashimoto, Xuetao Shi, Hirokazu Kaji   +8 more
wiley   +1 more source

Comparing percutaneous coronary intervention and thrombolysis in patients with return of spontaneous circulation after cardiac arrest

Clinics, 2013
OBJECTIVE: To evaluate the effects of percutaneous coronary intervention and thrombolysis after restoration of spontaneous circulation in cardiac arrest patients with ST-elevation myocardial infarction using meta-analysis.
Ying-Qing Li, Shu-Jie Sun, Na Liu, Chun-Lin Hu, Hong-Yan Wei, Hui Li, Xiao-Xing Liao   +6 more
doaj  

Does Ad Hoc Coronary Intervention Reduce Radiation Exposure? – Analysis of 568 Patients

Arquivos Brasileiros de Cardiologia, 2015
Background:Advantages and disadvantages of ad hoc percutaneous coronary intervention have been described. However little is known about the radiation exposure of that procedure as compared with the staged intervention.Objective:To compare the radiation ...
Márcio A. M. Truffa, Gustavo M.P. Alves, Fernando Bernardi, Antonio Esteves Filho, Expedito Ribeiro, Micheli Z. Galon, André Spadaro, Luiz J. Kajita, Raul Arrieta, Pedro A. Lemos   +9 more
doaj   +1 more source

Use of prasugrel vs clopidogrel and outcomes in patients with acute coronary syndrome undergoing percutaneous coronary intervention in contemporary clinical practice: Results from the PROMETHEUS study [PDF]

, 2017
Background and objectivesWe sought to determine the frequency of use and association between prasugrel and outcomes in acute coronary syndrome patients undergoing percutaneous coronary intervention (PCI) in clinical ...
Aquino, M, Baber, U, Baker, BA, Bansilal, S, Chandrasekhar, J, Defranco, A, Effron, M, Henry, TD, Kapadia, S, Keller, S, Kini, A, Marrett, E, Mehran, R, Muhlestein, JB, Pocock, S, Poddar, KL, Rao, SV, Sartori, S, Strauss, C, Toma, C, Weintraub, W, Weiss, S   +21 more
core   +2 more sources

CYP2C19 genotype testing for clopidogrel: A guideline developed by the UK Centre of Excellence in Regulatory Science and Innovation in Pharmacogenomics (CERSI‐PGx)

British Journal of Clinical Pharmacology, EarlyView.
Clopidogrel, an antiplatelet agent, is currently licensed in the United Kingdom for the prevention and treatment of atherothrombotic events in cerebrovascular disease, coronary artery disease and peripheral arterial disease. Clopidogrel requires metabolic activation by the cytochrome P450 enzyme CYP2C19 to be effective.
Cinzia Dello Russo, Iain Frater, Rebecca Kuruvilla, Stefanie Lip, Hannah O'Neill, Kerry Burke, Vicky Chaplin, Alexander S. F. Doney, Salim Elyas, Nicholas Greaves, Sophie Harding, David Hargroves, Judith Hayward, Dyfrig A. Hughes, Tom A. T. Hughes, Sree Kondapally, Patrick Mok, Aaron Peace, Imran Rafi, Simon Ray, Vicky Stinton, Luigi Venetucci, Munir Pirmohamed   +22 more
wiley   +1 more source

Coronary angiography in heart failure: when and why? Uncertainty reigns [PDF]

, 2017
No abstract ...
Petrie, Mark C., Rocchiccioli, Paul
core   +1 more source